| Lista | Sección | Observación |
|---|---|---|
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | C. APARELHO CARDIOVASCULAR | Sin observaciones |
| Lista | Sección | Observación |
|---|---|---|
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 1.11.2 Statins | Sin observaciones |
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | C. APARELHO CARDIOVASCULAR | Sin observaciones |
| El Salvador - 2019 | AGENTES QUE REDUCEN LOS LÍPIDOS SÉRICOS | Sin observaciones |
| Chile. Formulario Nacional de Medicamentos. 2005 | 11.06. HIPOLIPEMIANTES | Sin observaciones |
| Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 | 24.06 Antilipidemic agents | Sin observaciones |
| Guyana. Essential Medicines List. 2020-2021 | Lipid-lowering Medicines | Sin observaciones |
| Barbados. Barbados National Drug Formulary (BNDF) | 24.06.08 HMG-CoA Reductase Inhibitors | Sin observaciones |
| Bahamas. Drug Formulary | 02. CARDIOVASCULAR DRUGS | Sin observaciones |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 02.12 Lipid-Regulating Drugs | Sin observaciones |
| Lista | Sección | Observación |
|---|---|---|
| Peru | 12.6 Hypolipidemiants | Sin observaciones |
| El Salvador - 2019 | AGENTES QUE REDUCEN LOS LÍPIDOS SÉRICOS | Sin observaciones |
| Lista | Sección | Observación |
|---|---|---|
| Peru | 12.6 Hypolipidemiants | Sin observaciones |
| Lista | Sección | Observación |
|---|---|---|
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 1.11.2 Statins | Sin observaciones |
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | C. APARELHO CARDIOVASCULAR | Sin observaciones |
| Barbados. Barbados National Drug Formulary (BNDF) | 24.06.08 HMG-CoA Reductase Inhibitors | Sin observaciones |
| Bahamas. Drug Formulary | 02. CARDIOVASCULAR DRUGS | Sin observaciones |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 02.12 Lipid-Regulating Drugs | Sin observaciones |